Ventricular Arrhythmias and Sudden Cardiac Death: Mechanism, Ablation, and Defibrillation

Ventricular arrhythmias and sudden death are responsible for hundreds of thousands of deaths each year throughout the world. Covering the most recent developments in this field, this leading text serves as a guide to this area of increasing clinical importance, addressing a wide range of topics, including:

basic mechanisms of ventricular tachycardia and ventricular fibrillation
clinical syndromes and etiologies
epidemiology and risk stratification
pharmacologic therapy
ablation and surgery
implantable defibrillators.
Ventricular Arrhythmias and Sudden Cardiac Death provides the information that cardiologists, cardiac electrophysiologists, cardiac electrophysiology fellows, scientists, industry, and associated professionals need to know about current and evolving Ventricular Tachyarrhythmia treatment and diagnosis. As the most comprehensive book on this topic, it will serve as the text that this readership will turn to first.

Spis treści:
List of contributors.
Foreword: Hein J. Wellens.
Part 1 Mechanisms of VT.
1 The role of spatial dispersion of repolarization and intramural reentry in inherited and acquired sudden cardiac death syndromes: Charles Antzelevitch (Masonic Medical Research Laboratory).
2 Mechanisms of ventricular tachycardia: underlying pathological and physiological abnormalities: Jacques MT de Bakker (Academic Medical Center, Amsterdam and University Medical Center Utrecht), Harold VM van Rijen (University Medical Center Utrecht).
Part 2 Etiologies and syndromes.
3 Time–dependent gender differences in the clinical course of patients with the congenital long–QT syndrome: Ilan Goldenberg (University of Rochester Medical Center), Arthur J. Moss (University of Rochester Medical Center), Wojciech Zareba (University of Rochester Medical Center).
4 Genetics of ventricular arrhythmias: Zian H. Tseng (University of C alifornia, San Francisco), Jeffrey Olgin (University of California, San Francisco).
5 Arrhythmogenic right ventricular dysplasia/cardiomyopathy: Rahul Jain (The Johns Hopkins University School of Medicine), Hugh Calkins (Johns Hopkins Medical Institutions).
6 Risk stratification and the implantable defibrillator for the prevention of sudden death in hypertrophic cardiomyopathy: Barry J. Maron (Minneapolis Heart Institute Foundation).
Part 3 Catheter and surgical ablation.
7 Mapping and ablation of ventricular tachycardia after myocardial infarction: William G. Stevenson (Brigham and Women’s Hospital), Usha Tedrow (Brigham and Women’s Hospital).
8 Mapping and ablation of ventricular tachycardia in nonischemic cardiomyopathy: Henry H. Hsia (Stanford University Medical Center), Pirooz S. Mofrad (Stanford University Medical Center).
9 Mapping to define scars and isthmuses: a new paradigm for guiding ventricular tachycardia ablation: Kyoko Soejima (Keio University).
10 Ablation of idiopathic ventricular tachycardias: Nitish Badhwar (University of California, San Francisco), Melvin M. Scheinman University of California, San Francisco.
11 Ablation of ventricular fibrillation: Karen P. Phillips (Cleveland Clinic Foundation), J. David Burkhardt (Cleveland Clinic Foundation), Robert A. Schweikert (Cleveland Clinic Foundation), Walid I. Saliba (Cleveland Clinic Foundation), Andrea Natale (Cleveland Clinic Foundation).
12 Ablation of ventricular tachycardia in congenital heart disease: George F. Van Hare (Stanford University School of Medicine and UCSF).
13 Role of imaging techniques in catheter ablation of ventricular tachycardia: Mathew D. Hutchinson (University of Pennsylvania Health System), David J. Callans (University of Pennsylvania Health System).
14 Epicardial ablation of ventricular tachycardia: Mauricio Scanavacca (University of Sao Paulo Medical School), Eduardo Sosa (University of Sao Paulo Medical School).
15 Role of catheter control systems in ablation of ventricular tachycardia: Marco Perez (Stanford University), Amin Al–Ahmad (Stanford University Medical Center).
16 Current surgical techniques for ischemic ventricular tachycardia: Robert J. Moraca (Washington University School of Medicine), Marci S. Bailey (Washington University School of Medicine), Ralph J. Damiano Jr (Washington University School of Medicine).
Part 4 Epidemiology, risk stratification, and pharmacological therapy for ventricular tachycardia and sudden death.
17 Epidemiology and etiologies of sudden cardiac death: Keane K. Lee (Stanford University Medical Center), Amin Al–Ahmad (Stanford University Medical Center), Paul J.Wang (Stanford University Medical Center), Robert J. Myerburg (University of Miami).
18 Non–invasive tests for risk stratification in ischemic and non–ischemic cardiomyopathy: J. Thomas Bigger (Columbia University College of Physicians and Surgeons), Mark C. Haigney (Uniformed Services University), Robert E. Kleiger (Washington University School of Medicine).
19 Risk stratification: where we are and where do we go from here: Jeffrey J. Goldberger (Feinberg School of Medicine, Northwestern University).
20 Pharmacological management of ventricular arrhythmias: Kevin J. Makati (Tufts–New England Medical Center), Munther Homoud (Tufts–New England Medical Center), Mark S. Link (Tufts–New England Medical Center), Jonathan Weinstock (Tufts–New England Medical Center), N.A. Mark Estes III (Tufts University School of Medicine).
Part 5 Ventricular fibrillation and defibrillation.
21 The mechanisms of ventricular fibrillation: Lan S. Chen (Indiana University School of Medicine), Peng–Sheng Chen (Indiana University School of Medicine), Moshe S. Swissa (The Hebrew University).
22 Mechanisms of defibrillation: Derek J. Dosdall (University of Alabama at Birmingham), Jian Huang (University of Alabama at Birmingham), Raymond E. Ideker (University of Alabama at Birmingham).
23 Automatic external defibrillation and public access defibrillator response: Paul J. Wang (Stanford University Medical Center), Amin Al–Ahmad (Stanford University Medical Center), Robert J. Myerburg (University of Miami).
24 Advances in cardiopulmonary rescuscitation: Anurag Gupta (Stanford University Medical Center), Amin Al–Ahmad (Stanford University Medical Center).
25 Advances in implantable defibrillator therapy and technologies: Paul J. Wang (Stanford University Medical Center), Amin Al–Ahmad (Stanford University Medical Center), Henry H. Hsia (Stanford University Medical Center), Paul C. Zei (Stanford University Medical Center).
26 ICD lead extraction: when, why and how?: Bruce L. Wilkoff (Cleveland Clinic Foundation), Oussama Wazni (Cleveland Clinic Center for Cardiovascular Research).
Index

Nota biograficzna:
Paul J. Wang, MD
Cardiovascular Medicine, Department of Medicine
Stanford University Medical Center
Stanford, CA, USA
Henry H. Hsia, MD
Cardiovascular Medicine, Department of Medicine
Stanford University Medical Center
Stanford, CA, USA
Amin Al–Ahmad, MD
Cardiovascular Medicine, Department of Medicine
Stanford University Medical Center
Stanford, CA, USA
Paul C. Zei, MD
Cardiovascular Medicine, Department of Medicine
Stanford University Medical Center
Stanford, CA, USA

Okładka tylna:
Ventricular arrhythmias and sudden death are responsible for hundreds of thousands of deaths each year throughout the world. Covering the most recent developments in this field, this leading text serves as a guide to this area of increasing clinical importance, addressing a wide range of topics, including:

basic mechanisms of ventricular tachycardia and ventricular fibrillation
clinical syndromes and etiologies
epidemiolog